Qingfei phlegm Collaterals treatment of chronic obstructive pulmonary disease with acute exacerbation of the clinical data of 34 patients.doc

 PAGE \* MERGEFORMAT 17 Qingfei phlegm Collaterals treatment of chronic obstructive pulmonary disease with acute exacerbation of the clinical data of 34 patients [Abstract] Objective To study traditional Chinese medicine meridians Qingfei phlegm treatment of chronic obstructive pulmonary disease (COPD) with acute exacerbation of the clinical efficacy and mechanism. Methods 68 patients with acute exacerbation of COPD were divided into treatment group and control group, control group, 34 cases in accordance with the “diagnosis and treatment of chronic obstructive pulmonary disease guidelines,” according to the severity level given individual treatment, the treatment group, 34 patients treated with the control group on the basis of taking the same clearing the lungs phlegm and collaterals traditional Chinese medicine. the treatment group and the control group, the total effective rate was 91.18%, 88.24% (Pgt; 0.05), clinical control rate was 67.65%, 52.94% (P lt;0.05), treatment group 2 were significantly improved lung function, more improvement in the treatment group more obvious control group (P lt;0.05), group 2 after treatment sputum interleukin -8 (IL-8), serum cell adhesion molecule (sICAM-1) levels were decreased in the treatment group more significantly than the control group (P lt;0.05). Qingfei phlegm and collaterals of the acute exacerbation of COPD have a better therapeutic effect, its mechanism may control IL-8 and sICAM-1 levels to control airway inflammation. [Keywords:] Chronic obstructive pulmonary disease; Qingfei phlegm and collaterals, Interleukin -8; cell adhesion molecule -1. Keywords:: COPD, Qingfei Huatan Tongluo method, interleukin-8, cellular adhesion molecule-1 In recent years, chronic obstructive pulmonary disease (COPD) become more and more widespread concern and attention. We use the method of combining Chinese and Western treatment of acute exacerbations of COPD have achieved good clinical efficacy and mechanism of thei